2-Arylidenebenzosuberones react with a Wittig-Horner reagent in the presence of sodium hydride as a base to give the novel dimethyl (4-(4-methoxyphenyl)-2-oxa-2, 3,4,5,6,7-hexahydrobenzo-[6,7]cyclohepta[1,2-b]pyran-3-yl)phosphonate. On the other hand, 6,7-dihydrobenzo [6, 7] cyclohepta-[1,2-b]pyran-2(5H)-ones were isolated from the reaction of 2-arylidenebenzosuberones with WittigHorner reagents using alcoholic sodium alkoxide. The reaction of 2-arylidenebenzosuberones with trialkyl phosphites affords the alkyl phosphonate derivatives. Tris(dialkylamino)phosphines react with 2-arylidenebenzosuberones to give the oxaphospholanoxide products. 2-Arylidenebenzosuberones react with Lawesson's reagent to yield the corresponding dimers. Some of the prepared products were screened for antitumor activity.
Introduction
Benzosuberone derivatives are known as cytotoxic and antitumor agents against L1210 murine leukemia and HT2g cell lines [1 -3] , as potent inhibitors of tubulin polymerization [4] and as blood platelet aggregation inhibitors [5] . This together with our interest in organophosphorus chemistry [6 -11] has encouraged the synthesis of new organophosphorus compounds incorporating such structural units that may possibly lead to further biological activity. The present study deals with the reaction of 6-arylidene-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ones 1 with Wittig-Horner reagents 2, trialkyl phosphites 3, tris(dialkylamino)-phosphines 4, and Lawesson's reagent 5 (Scheme 1). Scheme 1. c 2012 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com
Results and Discussion

Chemistry
When benzosuberone 1a was treated with one equivalent of trimethyl phosphonoacetate 2a in dry xylene in the presence of sodium hydride at reflux temperature for 10 h, compound 6a was obtained (75 % yield) (Scheme 2). Compound 6a was formulated as lactone 6a. Elemental and mass spectral analysis of 6a led to an empirical formula C 23 H 25 O 6 P. The IR spectrum of 6a in KBr revealed of strong absorption bands at 1230 cm −1 (P=O, bonded) [12] and at 1050 cm −1 (P-O-C) [12] . Moreover, the IR spectrum showed a carbonyl absorption band at 1726 cm −1 (CO, lactone). The spectrum of 6a lacked the carbonyl absorption which is recorded [13] for 1a at 1660 cm −1 . The 1 H NMR spectrum of 6a gave signals at δ = 1.23 ppm (m, 2H, CH 2 ), 1.79 ppm (m, 2H, CH 2 ), 2.6 ppm (m, 2H, CH 2 ). The two ortho-methine protons appeared as a pair of doublets at 2.7 ppm (dd, 2 J HP = 15 Hz, J HH = 7.5 Hz), and 5.6 ppm (dd, 3 J HP = 10 Hz,J HH = 7.5 Hz). Moreover, the 1 H NMR of 6a exhibited signals at 3.4 ppm (s, 3H, C 6 H 4 -OCH 3 ) and 3.5, 3.6 ppm (2d, 6H, 3 J HP = 11 Hz, PO(OCH 3 ) 2 ) for the two methoxy groups attached to the phosphorus and a multiplet at 6.9 -7.1 ppm (8H, aromatic). The 31 P NMR measurement of 6a supported the phosphonate structure. It exhibited a sharp signal at δ = Scheme 2. 23.03 ppm [14] . The 13 C NMR spectrum of 6a added good support for the proposed structure and revealed the methine proton attached to the phosphorus as a doublet at 33.4 ppm with 1 J CP = 168.8 Hz.
When 1a was allowed to react with one equivalent of trimethyl phosphonoacetate 2a, in a methanolic sodium methoxide solution, adduct 7a was isolated in 80 % yield (Scheme 2). The structure 7a was established from its elemental analysis and its IR, 1 H, 13 C NMR and mass spectral data (cf. Experimental Section). Similarly, when 1b was allowed to react with trimethyl phosphoacetate 2a in a methanolic sodium methoxide solution, 7b was obtained (78 % yield) (Scheme 2, cf. Experimental Section). When 2-benzylidene-1-benzosuberones 1a and 1b were allowed to react with phosphonate 2b in an alcoholic sodium ethoxide solution, pyranones 7a and 7b were also isolated (Scheme 2).
A possible explanation for the reaction course of 1a with Wittig-Horner reagent 2a in the presence of sodium hydride as base is shown in Scheme 2. Initial attack of trimethyl phosphonacetatete 2a on the most reactive center of 1a gave the intermediate A. Elimination of one molecule of alcohol followed by cyclization result in the formation of the phosphonate derivative 6a. Compounds 7a,b presumably are also formed via intermediate A. Under the influence of the base present in the reaction medium, elimination of dialkyl Scheme 3. phosphite together with the loss of one molecule of alcohol and cyclization after a suitable proton transfer gives the final products 7a and/or 7b (Scheme 2). The dialkyl phosphite was detected in the water layer by the development of a violet color on addition of 3,5-dinitrobenzoic acid [15] . Moreover, when 6a was allowed to react with sodium methoxide in an alcoholic solution under reflux for 6 h, compound 7a was obtained (60 % yield). The dialkyl phosphite was again detected in the water layer.
Furthermore, this study was extended to include the behavior of benzosuberone 1a towards trimethyl phosphite 3a to determine the preferential site of attack. We have found that the reaction of 1a with 3a was successfully completed (TLC) by using an excess of phosphite as solvent and heating the mixture for 4 h at 105 • C. Separation of the product mixture yielded phosphonate 8a (75 % yield) (Scheme 3). Compound 8a was chromatographically pure and shows a sharp melting point. The assigned methylphosphonate structure 8a is based on correct microanalysis and IR, 1 H, 13 C, 31 P NMR and mass spectral data.
The IR spectrum of 8a revealed the presence of the carbonyl absorption band at 1660 cm −1 . In addition, it exhibited intense bands corresponding to the P=O (1256 cm −1 ) and P-O-alkyl (1082 cm −1 ) stretching vibrations [12] 2 ), 157 (C-OCH 3 ), and 205.6 ppm (C=O). The mass spectrum of 8a showed the molecular ion peak at m/z = 386 (30 %), and the peak for [M-P(O)(OCH 3 ) 2 ] + at m/z = 278 (90 %). Similarly, 2-benzylidene-1-benzosuberone (1a) reacts with an excess of triisopropyl phosphite 3b as solvent to give 8b (70 % yield). The structure of 8b is derived from its spectral data (cf. Experimental Section). When benzosuberone 1b reacted with an excess of (3b) as solvent, product 8c was obtained (65 % yield). Methyl phosphonate 8c has been identified on the basis of its elemental analysis and its IR, 1 H, 13 C, 31 P NMR and mass spectral data (Scheme 3, cf. Experimental Section). Worthy to mention is that only one isomer of phosphonate 6a and compound 8 were isolated, which are assumed to have a cis configuration. The assigned cis configuration for these products, although not established with certainty, is supported by an inspection of Newman projections [16] as well as by the 1 H NMR chemical shifts and coupling constants of the two ortho me- Scheme 4. thine protons attached to phosphorus. The observed coupling constants of (J H a H b = J H b H a , ca. 6 -7.5 Hz) indicate a cis configuration, rather than a trans configuration which would give rise to larger coupling constants (9 -15 Hz).
We have found that 1a reacted with tris(dimethylamino)phosphine (4a) in refluxing toluene to give a chromatographically pure adduct formulated as 9a (Scheme 4). The structure elucidation of product 9a is based on the following evidences. Elemental analysis and molecular weight determination (MS) of 9a supported the molecular formula C 21 H 24 NO 3 P (369.39). The IR spectrum, in KBr, exhibited an intense band at 1240 cm −1 corresponding to the P=O absorption, and two bands at 1320 cm −1 and 860 cm
due to the absorption of P-N(CH 3 ) 2 [17] . Moreover, the IR spectrum of the oxaphosphole-2-oxide 9a revealed the absence of the carbonyl absorption which is recorded for 1a at 1660 cm −1 . The 1 H NMR spectrum of 9a showed signals at δ = 3.5 (d, 1H, 2 J HP = 18.5 Hz) for the methine proton attached to the phosphorus, 2.8 (d, 6H, 3 J HP = 11.10 Hz)
for the dimethyl amino group, a singlet at 3.8 (3H, C 6 H 4 -OCH 3 ), and multiplets at 1.8, 2.3, 2.8 ppm (3CH 2 ). The aromatic protons appeared as multiplets at δ = 6.9 -7.9 ppm (8H). The 31 P NMR spectrum of 9a gave one signal at δ = 43.7 ppm that supported the cyclic oxaphospholanoxide [14, 18] . Similarly, tris(diethylamino)phosphine (4b) reacts with 1a to give 9b (70 % yield). When 2-benzylidene-1-benzosuberone 1b reacted with 4a and 4b, the corresponding oxaphospholoxide derivatives 9c and 9d were obtained (Scheme 4). The structure of the new products 9b -d was deduced from their spectral data (cf. Experimental Section). These compounds were formed presumably through nucleophilic attack of the phosphitephosphorus on the most reactive center of 1 leading to the dipolar adduct A, which undergoes ring closure giving structure B. The latter, due to its structural features, could transform into the most stable form 9 through rapid hydrolysis (by the presence of unavoidable moisture) to give intermediate C, which undergoes further decomposition yielding com- Scheme 5. pound 9 [8, 18, 19] . Similar results have been reported previously [8, 19] .
Furthermore, this study was extended to include the behavior of 2-benzyliene-1-benzosuberones 1a, b toward Lawesson's reagent (5). We have found that 1a reacted with half a molar equivalent of 5 in refluxing toluene for 1 h to give the dimeric product 10a (65 % yield). Similarly, when 1b reacted with half an equivalent of 5 in refluxing toluene, the dimeric product 10b was obtained (60 % yield). The structures of 10a and 10b were confirmed by analytical and spectral data (Scheme 5, cf. Experimental Section).
The dimeric compounds 10a, b were formed through the straightforward thionation of carbonyl group of 1a, b to yield the thione monomer which immediately underwent cyclization with another thione monomer [2+4] to yield the corresponding thione dimers 10a and 10b (Scheme 5) [20] . It is worthy to note that when 1a and 1b react with phosphorus pentasulfide (P 4 S 10 ) in refluxing toluene, the dimeric compounds 10a and 10b were also obtained (Scheme 5).
Pharmacological evaluation
Cancer diseases are a serious threat to health and development of mankind, and searching for effective anti-cancer agents remain actual. Considerable progress has been made in recent years in the field of drug development against different types of cancer. Moreover, chemotherapy is a major approach for both localized and metastasized cancers [21] , and benzosuberone derivatives have proved to have a significant therapeutic potential [1 -3] . Based on these considerations, six of the newly synthesized compounds were screened for their in vitro cytotoxic and growth inhibitory activities against human breast adenocarcinoma cells (MCF 7) and/or human hepatocellular carcinoma (HEPG2). The cytotoxicity of the tested extracts was measured against MCF 7 cells and/or HEPG2 cells using the MTT Cell Viability Assay [22] . According to the American National Cancer Institute guidelines [23] drugs with IC 50 < 30 are active. The cytotoxicity of the extracts was tested in the Cancer Biology laboratory, Center of Excellence for Advanced Sciences, National Research Center.
Treatment of MCF 7 cells with sample 7a led to a high inhibition in the cell proliferation as concluded by the low IC 50 value of 13.32 µg mL −1 (Fig. 1) . On the other side, the other tested samples 6a, 8a, 9b, 10a, and 10b revealed a non-cytotoxic effect against of MCF 7 cells. Paclitaxel, a known anti-cancer drug, was used as a positive control, and its IC 50 was 0.452 µg mL −1 against MCF 7 cells. As shown in Table 1 , the treatment of HEPG2 cells with 7a, 9a, and 10b led to a high inhibition in the cell proliferation as concluded by the low IC 50 values of 27.89, 28.56, and 29.27 µg mL −1 , respectively, whereas the other samples 6a, 8a and 10a revealed a non-cytotoxic effect against HEPG2 cells. Paclitaxel, a known anti-cancer drug, was used as a positive control and its IC 50 was 0.517 µg mL −1 against HEPG2 cells.
Conclusion
The reaction of 2-benzylidene-1-benzosuberones 1 with Wittig-Horner reagents, trialkyl phosphites, tris(dialkylamino)phosphines and Lawesson's reagent leads to different products, depending on the reaction conditions as well as on the stability of the addition products. As a result pyran phosphonates, cycloheptapyranone, phosphonates benzocycloheptenes and oxaphospholoxide derivatives with anticipated biological activity could be obtained.
Experimental Section
Melting points were determined in open glass capillaries using an Electrothermal IA 9100 series digital melting point apparatus (Electorthermal, Essex, UK), and IR spectra were measured as KBr pellets with a Perkin-Elmer spectrophotometer model 157. The 1 H and 13 C NMR spectra were recorded in CDCl 3 or [D 6 ]DMSO as solvents on a Joel 500 (500/125 MHz) spectrometer. The chemical shifts δ (in ppm) are given relative to TMS as internal reference. The 31 P NMR spectra were taken with a Varian CFT-20 spectrometer (vs. external 85 % H 3 PO 4 as standard). The mass spectra were recorded at 70 eV with a Kratos MS equipment or a Varian MAT311A spectrometer. Elemental analyses were performed using an Elementar Vario E1 instrument. The reported yields correspond to pure isolated materials obtained by column chromatography on silica gel 60 (Merck). 2-benzylidene-1-benzosuberones 1a and 1b were prepared according to a reported method [24] .
Reaction of trimethyl phosphonoacetate 2a with 6-(4-methoxybenzylidene)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one 1a in the presence of sodium hydride
Trimethyl phosphonoacetate 2a (0.18 g, 1 mmol) was dissolved in dry xylene (25 mL), and sodium hydride (0.024 g, 1 mmol) was added carefully with stirring. Then the arylidene suberone 1a (0.27 g, 1 mmol) was added, and the mixture was refluxed for 10 h. After evaporation of the volatile material under reduced pressure, the residue was subjected to silica gel column chromatography to give compound 6a.
Dimethyl- (4-(4-methoxyphenyl)-2-oxo-2,3,4,5,6 ,7-hexahydrobenzo [6, 7] cyclohepta [1,2-b] 
Reaction of trimethyl phosphonoacetate 2a with 6-(4-methoxybenzylidene)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one 1a in the presence of sodium methoxide
A solution of sodium methoxide (0.054 g, 1 mmol) in absolute methanol (30 mL) was treated with an equimolar amount of trimethyl phosphonoacetate 2a (0.18 g, 1 mmol). Then 2-arylidenebenzosuberone 1a (0.27 g, 1 mmol) was added, and the reaction mixture was refluxed for 12 h (TLC). The mixture was poured on a small amount of water, extracted with ethyl acetate, and dried, and the extracts were evaporated under reduced pressure. The residue was subjected to silica gel column chromatography to give compound 7a. When compound 6a was reacted with sodium methoxide in alcoholic solution under reflux for 6 h, compound 7a was obtained in 60 % yield. 
4-(4-Methoxyphenyl)-6,7-dihydrobenzo[6,7]cyclohepta[1,2-b]pyran-2(5H)-one (7a)
Eluent
Reaction of trimethyl phosphonoacetate 2a with 6-benzylidene-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one 1b in the presence of sodium methoxide
A solution of sodium methoxide (1 mmol) in absolute methanol (30 mL) was treated with an equimolar amount of trimethyl phosphonoacetate 2a (0.18 g, 1 mmol). Then 1b (0.24 g, 1 mmol) was added, and the resulting reaction mixture was refluxed for 10 h (TLC). Then it was poured on a small amount of water, extracted with ethyl acetate, and dried, and the extracts were evaporated under reduced pressure. The residue was subjected to silica gel column chromatography to afford compound 7b. [6, 7] cyclohepta [1,2-b] 
4-Phenyl-6,7-dihydrobenzo
pyran-2(5H)-one (7b)
General procedure for the reaction of triethyl phosphonoacetate (2b) with 1a,1b
Sodium ethoxide (0.068 g, 1 mmol) in absolute alcohol (30 mL) was added to a solution of an equimolar amount of triethyl phosphonoacetate (2b) (0.22 g, 1 mmol), and then 1a or 1b (1 mmol) was added. The resulting mixture was refluxed for 4 h, then poured on a small amount of water, extracted with ethyl acetate, and dried, and the extracts were evaporated under reduced pressure. The residue was subjected to silica gel column chromatography. Elution of the column with petroleum ether (60 -80 • C)-ethyl acetate (95/5, v/v) to give products 7a, 7b (mixed melting points and comparative IR spectra with authentic samples).
Reaction of trimethyl phosphite (3a) with 1a
Excess trimethyl phosphite (3a) was added to 1a (0.27 g, 1 mmol) without solvent, and the reaction mixture was refluxed for 4 h at 105 • C (TLC). After evaporation of the volatile material under reduced pressure, the residue was washed several times with petroleum ether (60 -80 • C) to give compound 8a. 
Dimethyl-(6,7,8,9-tetrahydro-5-oxo-5H-benzocyclohepten-6-yl)(4-methoxyphenyl)methyl-phosphonate (8a)
Solvent
Reaction of triisopropyl phosphite (3b) with 1a
Excess triisopropyl phosphite (3b) was added to 1a (0.27 g, 1 mmol) without solvent. The reaction mixture was refluxed for 4 h. After evaporation of the volatile material under reduced pressure, the residue was subjected to silica gel column chromatography to give product 8b. 
Diisopropyl-(6,7,8,9-tetrahydro-5-oxo-5H-benzocyclohepten-6-yl)(4-methoxyphenyl)methyl phosphonate (8b)
Reaction of triisopropyl phosphite (3b) with 1b
Excess triisopropyl phosphite (3b) was added to 1b (0.24 g, 0.001 mol) without solvent. The reaction mixture was refluxed for 4 h. After evaporation of the volatile material under reduced pressure, the residue was subjected to silica gel column chromatography to give compound 8c. 
Diisopropyl((5-oxo-6,7,8,9-tetrahydro-5H-benzocyclohepten-6-yl)(phenyl)methyl)phosphonate (8c)
General procedure for the reaction of 2-arylidenebenzosuberones 1a,b with tris(dialkylamino)phosphines 4a,b
Tris(dialkylamino)phosphine 4 (1 mmol) was added to a solution of compound 1 (1 mmol) in dry toluene (30 mL), and the reaction mixture was refluxed for 7 h (TLC). After evaporation of the volatile material under reduced pressure, the residue was subjected to silica gel column chromatography to give the products 9a -d. [3, 4] cyclohepta [1,2-d] [3, 4] cyclohepta [1,2- [3, 4] cyclohepta [1,2-d] 
2-(Dimethylamino)-3-(4-methoxyphenyl)-3,4,5,6-tetrahydro-2H-benzo
2-(Diethylamino)-3-(4-methoxyphenyl)-3,4,5,6-tetrahydro-2H-benzo
2-(Diethylamino)-3-phenyl-3,4,5,6-tetrahydro-2H-benzo-
Reaction of Lawesson's reagent (5) with 1a
A mixture of 2-arylidene-benzosuberone 1a (0.27 g, 1 mmol) and Lawesson's reagent (5) (0.2 g, 0.5 mmol) was refluxed for 1 h in (30 mL) of dry toluene. The volatile material was evaporated under reduced pressure and the residue subjected to silica gel column chromatography to give product 10a.
Reaction of 1a with phosphorus pentasulfide
A mixture of 1a (0.27g, 1 mmol) and P 4 S 10 (0.02 g, 0.5 mmol) was refluxed for 2 h in 30 mL of dry toluene. A yellow powder precipitated after the evaporation of the volatile material. The solid material was collected and crystallized from methanol to give 10a (mixed melting point and comparative IR spectrum).
Reaction of 1b with phosphorus pentasulfide
A mixture of 1b (0.24 g, 1 mmol) and P 4 S 10 (0.02 g, 0.5 mmol) was refluxed for 2 h in 30 mL of dry toluene. The volatile material was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography. The dimeric compound 10b was separated using petroleum ether-ethyl acetate (95/5, v/v) as an eluent (mixed melting point and comparative IR spectrum).
Pharmacological activity Material and methods
Chemicals: All cell culture material was obtained from Cambrex BioScience (Copenhagen, Denmark). All chemicals were from Sigma/Aldrich, USA, unless otherwise indicated. All experiments were repeated three times.
Cell culture: Cells were routinely cultured in DMEM (Dulbeco's Modified Eagle's Medium), which was supplemented with 10 % fetal bovine serum (FBS), 2 mM Lglutamine, containing 100 units/mL penicillin G sodium, 100 units mL −1 streptomycin sulfate and 250 mg mL −1 amphotericin B. Cells were maintained at sub-confluence at 37 • C in humidified air containing 5 % CO 2 .
In vitro cytotoxicity assay: Cells (0.5×105 cells per well), in serum-free media, were plated in a flat bottom 96-well microplate, and treated with 20 µL of different concentrations of the tested extract for 48 h at 37 • C in a humidified 5 % CO 2 atmosphere. After incubation, media were removed, and 40 µL MTT solution per well was added and incubated for an additional 4 h. MTT crystals were solubilized by adding 180 µL of acidified isopropanol per well, and the plate was shaken at r. t., followed by photometric determination of the absorbance at 570 nm using a microplate ELISA reader. Triplicate repeats were performed for each concentration, and the average was calculated. Data were expressed as the percentage of relative viability compared with the untreated cells and the vehicle control, with cytotoxicity indicated by < 100 % relative viability.
Calculation: The percentage of relative viability was calculated using the following equation: [absorbance of treated cells/absorbance of control cells)] X 100.
Then the half-maximum inhibitory concentration (IC 50 ) was calculated from the equation of the dose response curve.
